A novel Peptamen-based enteral nutrition protocol for treatment of Crohn s disease A Pilot Trial
The purpose of this study is to evaluate the therapeutic feasibility of a Peptamen-based, oral nutrition dietary regimen for treatment of adult Crohn’s disease. Specifically we are evaluating if consuming 80-100% of caloric needs from Peptamen 1.5 for 4 weeks is feasible for the potential future use therapeutically in adult Crohn’s disease.
Digestive & Liver Health, Microbiota
Crohn?s disease, IBD, dietary intervention, enteral nutrition, inflammatory bowel disease